COMIRNATY KP.2 30 MICROGRAMOS/DOSIS DISPERSION INYECTABLE

Biontech Manufacturing Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: b602dd2090f18712
Drug Cima Aemps Name: COMIRNATY KP.2 30 MICROGRAMOS/DOSIS DISPERSION INYECTABLE
Register Number: 1201528038
Holder Company Name: Biontech Manufacturing Gmbh
Marketing Company Name: Pfizer S.L.
Holder Company Detail Path: /organization/biontech-manufacturing-gmbh
Authorization Date: 2024-10-03
Dosage Form: DISPERSIÓN INYECTABLE
Dose: 30 microgramos
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Biontech Manufacturing Gmbh
Company Detail Path: /organization/biontech-manufacturing-gmbh

VACUNA DE ARNM QUE CODIFICA LA PROTEINA DE LA ESPICULA (S) VIRAL DEL SARS-COV-2 (OMICRON KP.2)

30 µg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 3, 2024

Approval ID

b602dd2090f18712

Type

Standard